Network|City Event at the Leibniz Institute for Immunotherapy (LIT)

Over 30 interested citizens of Regensburg, along with members of the CSU parliamentary group and Mayor Dr. Astrid Freudenstein, visited the Leibniz Institute for Immunotherapy on Tuesday, March 25.

Date Published

March 28, 2025

Prof. Philipp Beckhove, Scientific Director, Prof. Dr. Matthias Edinger, and Prof. Dr. Hinrich Abken provided detailed information about the cutting-edge medical research at the LIT. The scientists fascinated their visitors with presentations on new approaches for treating severe diseases such as cancer, autoimmune diseases, and rejection reactions following transplants. They vividly described how research at the LIT in Regensburg is already benefiting seriously ill patients in clinical trials at multiple locations today.

Interested citizens of Regensburg, along with members of the CSU parliamentary group, with scientists at the Leibniz Institute for Immunotherapy: Prof. Dr. Matthias Edinger (5th from the left), Dr. Thomas Diefenthal (6th from the left), Prof. Dr. Philipp Beckhove (7th from the left), Prof. Dr. Hinrich Abken (8th from the left), Mayor Dr. Astrid Freudenstein (9th from the left). © Stadtmarketing Regensburg / Lisa Meyer

Network|City is a monthly event organized by Stadtmarketing Regensburg, serving as a network initiative between the city administration, businesses, and citizens. The event was initiated by BioPark Regensburg GmbH under the leadership of Dr. Thomas Diefenthal. The LIT is a player in the cluster of BioPark Regensburg GmbH, which promotes biotechnology, medical engineering, diagnostics and analytics, and the healthcare industry in the region.